Antithrombotic prophylaxis
Showing 26 - 50 of 3,044
Cardiovascular Diseases Trial (Novel yogurt drink, Placebo Drink)
Completed
- Cardiovascular Diseases
- Novel yogurt drink
- Placebo Drink
-
Limerick, IrelandUniversity of Limerick
Nov 2, 2022
Prevention of Venous Thromboembolism Trial in Italy (Application of Padua and IMPROVE Bleeding scores)
Unknown status
- Prevention of Venous Thromboembolism
- Application of Padua and IMPROVE Bleeding scores
-
Casale Monferrato, Alessandria, Italy
- +34 more
Feb 10, 2020
Safe and Timely Antithrombotic Removal (STAR) Registry
Recruiting
- Hemorrhage, Surgical
- +3 more
- CytoSorb
-
Vienna, Austria
- +11 more
Jan 17, 2023
Cytomegalovirus Infections, Transplant-Related Disorder Trial in Philadelphia (Letermovir 480 MG [Prevymis])
Not yet recruiting
- Cytomegalovirus Infections
- Transplant-Related Disorder
- Letermovir 480 MG [Prevymis]
-
Philadelphia, PennsylvaniaPenn Medicine at the University of Pennsylvania
Sep 27, 2023
Covid19 Trial in Tehran (intermediate dose Enoxaparin/ unfractionated heparin, standard prophylactic dose Enoxaparin/
Completed
- Covid19
- intermediate dose Enoxaparin/ unfractionated heparin
- +3 more
-
Tehran, Iran, Islamic Republic ofMasih Daneshvari Hospital
Aug 14, 2021
Mild Traumatic Brain Injury and Risk for Traumatic Intracranial
Completed
- Traumatic Intracranial Hemorrhage
- Brain Injuries
- no intervention, only observational study
-
Sundsvall, SwedenSundsvall Hospital
Nov 1, 2022
Hip Fractures, Pain, Acute, Hip Fracture Surgery Trial in Bangkok Noi (Post-admission FICB)
Recruiting
- Hip Fractures
- +4 more
- Post-admission FICB
-
Bangkok Noi, Bangkok, ThailandFaculty of Medicine Siriraj Hospital, Mahidol University
May 4, 2023
Myeloproliferative Neoplasms (MPN) and COVID-19
Recruiting
- Myeloproliferative Neoplasm
- COVID
-
New York, New York
- +43 more
Apr 4, 2022
Pulmonary Embolism, Trauma, Venous Thromboembolism Trial in London (Cook 'Celect' retrievable inferior vena cava filter)
Completed
- Pulmonary Embolism
- +2 more
- Cook 'Celect' retrievable inferior vena cava filter
-
London, Ontario, CanadaVictoria Hospital
Feb 25, 2021
Anticoagulants and Bleeding Disorders, Surgery, Regional Anesthesia Morbidity Trial in Winston-Salem (Enoxaparin)
Terminated
- Anticoagulants and Bleeding Disorders
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Baptist Medical Center
Dec 4, 2022
Stroke Trial in United States (Time-To-Treatment Randomization)
Recruiting
- Stroke
- Time-To-Treatment Randomization
-
Austin, Texas
- +14 more
Nov 2, 2022
COVID-19 Trial in Brazil (Rivaroxaban 10 mg)
Terminated
- COVID-19
- Rivaroxaban 10 mg
-
Feira de Santana, Bahia, Brazil
- +35 more
Jan 20, 2023
Comitial Prophylaxis in Neurosurgery in Undergone Intracranial
Active, not recruiting
- Anti-epileptic Prophylaxis in Intracranial Neurosurgery
-
Brest, FranceCHU Brest
Jan 2, 2023
Non-valvular Atrial Fibrillation Trial in Hangzhou (Dual antiplatelet, Novel oral anticoagulant)
Recruiting
- Non-valvular Atrial Fibrillation
- Dual antiplatelet
- Novel oral anticoagulant
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
Feb 27, 2023
Rheumatic Heart Disease Trial in Kampala (phenoxymethyl penicillin, intramuscular benzathine penicillin G (BPG) prophylaxis)
Not yet recruiting
- Rheumatic Heart Disease
- phenoxymethyl penicillin
- intramuscular benzathine penicillin G (BPG) prophylaxis
-
Kampala, UgandaUganda Heart Institute
Jan 11, 2023
Early-Onset Neonatal Sepsis Trial (Procalcitonin/Presepsin guided antibiotic prophylaxis for EOS, Antibiotic prophylaxis for
Not yet recruiting
- Early-Onset Neonatal Sepsis
- Procalcitonin/Presepsin guided antibiotic prophylaxis for EOS
- Antibiotic prophylaxis for EOS
- (no location specified)
Mar 21, 2023
Infections, Cytomegalovirus Trial in Cordoba (Letermovir 240 mg Oral Tablet)
Not yet recruiting
- Infections, Cytomegalovirus
- Letermovir 240 mg Oral Tablet
-
Cordoba, Córdoba, SpainHospital Universitario Reina Sofia
Sep 25, 2023
COVID-19, SARS-CoV-2 Trial in Moscow, St Petersburg (Biological: AZD3152, Biological: Placebo)
Not yet recruiting
- COVID-19, SARS-CoV-2
- Biological: AZD3152
- Biological: Placebo
-
Moscow, Russian Federation
- +5 more
Sep 26, 2023
Covid19 Trial in United States (Apixaban 2.5 MG, Placebo)
Active, not recruiting
- Covid19
- Apixaban 2.5 MG
- Placebo
-
Phoenix, Arizona
- +120 more
Jul 1, 2022
Antithrombotic Management of Acute Mesenteric Ischaemia
Not yet recruiting
- Acute Mesenteric Ischemia
- Short Bowel Syndrome
- Survey
- (no location specified)
Jan 20, 2023
Left Ventricular Thrombus, ST Segment Elevation Myocardial Infarction Trial in Tehran (Rivaroxaban 15 MG, Warfarin)
Recruiting
- Left Ventricular Thrombus
- ST Segment Elevation Myocardial Infarction
- Rivaroxaban 15 MG
- Warfarin
-
Tehran, Iran, Islamic Republic of
- +1 more
Jan 21, 2023
Venous Thromboembolism and Bleeding Events inPopulation of Obese
Not yet recruiting
- Venous Thromboembolism
- (no location specified)
Apr 6, 2023
Atrial Fibrillation Trial in Xi'an (Rivaroxaban 15mg, Aspirin 100mg, Clopidogrel 75mg)
Recruiting
- Atrial Fibrillation
- Rivaroxaban 15mg
- +4 more
-
Xi'an, Shannxi, ChinaLing Tao
Jul 24, 2023